baber/WOPTO huggingface dataset:
Patent AU-2012201175-B2 (AU)
Title: Pneumatic tyre
Inventor: KUDO DAISUKE
IPC: B60C11/12
Filed: 2012-02-28
Granted: 2014-08-28
Abstract: PNEUMATIC TYRE Abstract A pneumatic tyre (1) is provided with center blocks (19) defined by a central main groove (10), shoulder main grooves (11) and central axial grooves (14), and shoulder blocks (20) defined by the shoulder main grooves (11), shoulder axial grooves (15) and the tread edges (Te). The tread profile comprises a center arc (K2) of a radius of 250 to 550 mm and a shoulder arc of a smaller radius and has a camber quantity of 5.5 to 9.0 mm. The center blocks and shoulder blocks are provided with sipes each having an axially outer open end and an axially inner closed end disposed at specific positions in relation to the axially inwardly adjacent main grooves. The total sipe number on the shoulder blocks is more than the total sipe number on the center blocks. Cr 2 21 14 11 2A 22 15 Te ---A - Bs LA K1 Sh R 2 6(6A)H 6b
Patent AU-2012201560-B2 (AU)
Title: A fan assembly
Inventor: GAMMACK PETER
IPC: F04D25/08
Filed: 2012-03-15
Granted: 2013-07-04
Abstract: A Fan Assembly A fan assembly for creating an air current comprises an air outlet (14) mounted on a stand (12). The stand (12) comprises a base (38, 40) and a body (42) tiltable relative to the base (38, 40). Each of the base (38, 40) and the body (42) has an outer surface shaped so that adjoining portions of the outer surfaces (102, 160) are substantially flush when the body (42) is in the untilted position. (Figure 1) -92
Patent AU-2012204844-B2 (AU)
Title: Dissolution and recovery of at least one element Nb or Ta and of at least one other element U or rare earth elements from ores and concentrates
Inventor: AGIN JEROME
IPC: C22B1/06
Filed: 2012-01-06
Granted: 2016-06-02
Abstract: The main subject-matter of the present invention is a process for the dissolution of at least one element chosen from niobium and tantalum and at least one other element chosen from uranium and the rare earth elements, advantageously for the dissolution of niobium, tantalum, uranium and rare earth elements, present in an ore or an ore concentrate. Said process comprises: - the roasting of a material, comprising said elements, which material is mixed, dry or/in the presence of water, with an acid roasting agent in order to obtain a calcine; said material consisting of said ore or concentrate or having been obtained from said ore or said concentrate and said acid roasting agent providing for roasting in a sulphate medium; and - the dissolution in an aqueous solution of the calcine obtained in order to obtain a slurry, the liquid fraction of which includes iron, in the ferric state, at a concentration of at least 50 g/l, advantageously of at least 70 g/l and very advantageously of at least 120 g/l.
Patent AU-2012220314-B2 (AU)
Title: Cystamine analogues for the treatment of Parkinson's disease
Inventor: CICCHETTI FRANCESCA
IPC: A61P25/28
Filed: 2012-02-23
Granted: 2017-04-06
Abstract: The present invention relates to the use of cystamine analogues for the treatment of Parkinson's disease. The present invention also relates to the use of composition comprising cystamine analogues and cysteine. The present invention relates to a method for modifying the progression of Parkinson's disease comprising administering a therapeutically effective amount of at least one cystamine analogue or a pharmaceutically acceptable salt of a cystamine analogue to a patient in need thereof.
Patent AU-2012227286-B2 (AU)
Title: Device and method for source mechanism identification
Inventor: DE CACQUERAY BENOIT
IPC: G01V1/24
Filed: 2012-09-24
Granted: 2015-12-10
Abstract: Computing device, software and method for identifying a source mechanism associated with a microseismic event taking place in a subsurface of the earth. The method includes receiving traces associated with a plurality of receivers located in a grid above the subsurface; dividing the grid in a set of sub-blocks, each sub-block including one or more receivers of the plurality of receivers; determining, for each sub-block, a corresponding summation element based on traces associated with the corresponding sub-block; identifying a predetermined number of patterns that are associated with plural source mechanisms; multiplying each summation element by a polarization coefficient according to a corresponding pattern; calculating in the computing device, for each pattern, a semblance function based on summation elements of the sub-blocks; and identifying the source mechanism of the microseismic event based on the semblance function. A pattern includes a first subset of the sub-blocks having positive polarity and a second subset of the sub blocks having negative polarity, and the first subset together with the second subset form the entire set of the sub-blocks. Figure 17 Receiving traces associated with a plurality of receivers located in a grid above the subsurface Dividing the grid in a set of sub-blocks, each sub-block including one or more receivers of the plurality of receivers Determining, for each sub-block, a corresponding summation element based on traces associated with the corresponding sub-block r_1 706 Identifying a predetermined number of patterns that are associated with plural source mechanisms Calculating in the computing device, for each pattern, a semblance function based on summation elements of the sub-blocks Identifying the source melanism of the microseismic event based on the semblance function
Patent AU-2012251971-B2 (AU)
Title: Polymeric nanoparticles for drug delivery
Inventor: GOMEZ SALVADOR BORROS
IPC: A61K9/51
Filed: 2012-05-09
Granted: 2015-04-30
Abstract: Disclosed are nanoparticles comprising a block copolymer and optionally one or more active agent(s), compositions comprising said nanoparticles and methods of preparing said nanoparticles. The block copolymer comprises blocks (i) a first polymer that is a polyester or polyamide and (ii) a second polymer comprising a hydrocarbon chain containing ester or ether bonds with hydroxyl number ≥ 10. The active agent(s) may be present within the nanoparticles or on the surfaces of the nanoparticles. The nanoparticles may optionally be associated with a surface-modifying moiety such that they are useful as drug delivery and molecular imaging devices. The surface-modifying moiety may target the nanoparticles to a desired target, cell, tissue or biomarker.
Patent AU-2012255641-B2 (AU)
Title: Preparation of soy protein isolate using calcium chloride extraction ("S703 CIP")
Inventor: SEGALL KEVIN L
IPC: A23L11/00
Filed: 2012-05-09
Granted: 2016-05-19
Abstract: A soy protein product having a protein content of at least about 60 wt% (N x 6.25) d.b., preferably an isolate having a protein content of at least about 90 wt% (N x 6.25) d.b., is formed by a procedure in which soy protein is extracted from a soy source material using an aqueous calcium chloride solution at low pH, generally about 1.5 to about 5, and separating the resulting aqueous soy protein solution from residual soy protein source. The resulting clarified aqueous soy protein solution may be diluted and the pH adjusted within the range of 1.5-5.0. The solution may be concentrated by ultrafiltration, diafiltered and then dried to provide the soy protein product. Alternatively, the concentrated and optionally diafiltered soy protein solution may be optionally adjusted in pH within the range of 1.5-7.0 then diluted into water to cause the formation of a precipitate, separating the precipitate from the diluting water (supernatant) and drying the separated soy protein to form a soy protein product having a protein content of at least about 60 wt% (N x 6.25) d.b., preferably a soy protein isolate having a protein content of at least about 90 wt% (N x 6.25) d.b.. The supernatant may be processed to form soy protein products having a protein content of at least about 60 wt% (N x 6.25) d.b., preferably a soy protein isolate having a protein content of at least 90 wt% (N x 6.25) d.b.. Alternatively, the precipitate from the dilution step may be re-solubilized in the diluting water by adjustment of the pH to resolubilize the precipitate and form a protein solution. The soy protein solution may be concentrated while maintaining the ionic strength substantially constant by using a selective membrane technique followed by optional diafiltration and drying. The soy protein product is soluble in acidic medium and produces transparent, heat stable solutions and hence may be used for protein fortification of soft drinks and sports drinks.
Patent AU-2012272790-B2 (AU)
Title: Anti-alpha synuclein binding molecules
Inventor: WEIHOFEN ANDREAS
IPC: A61K39/395
Filed: 2012-06-22
Granted: 2016-10-06
Abstract: Provided are anti-human α-synuclein-specific binding molecules, e.g., antibodies or antiben-binding fragments, variants or derivatives thereof, as methods related thereto. Further provided are anti-human α-synuclein binding molecules which bind to specific N-terminal and C-terminal epitopes on human α-synuclein. The binding molecules described herein can be used in pharmaceutical and diagnostic compositions for α-synuclein targeted immunotherapy and diagnosis, respectively.
Patent AU-2012290089-B2 (AU)
Title: Vitamin B6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates
Inventor: KARPEISKY ALEXANDER
IPC: A01N57/00
Filed: 2012-08-01
Granted: 2016-09-29
Abstract: Compounds, compositions, and methods of using them to treat infections, neoplastic disease, inflammatory disease, and pain. Such compounds are nucleotides, acydonucleotides, and acydic nucleoside phosphonates (ANP) phosphonates conjugated with forms and/or moieties of Vitamin B6 for delivery past the cell membrane and into the cell. Methods of delivering nucleotides, acydonucleotide and ANPs to the inside of the cell by conjugating said compounds with forms and/or moieties of Vitamin B6.
Patent AU-2012290972-B2 (AU)
Title: Method for decoding video
Inventor: SEGALL CHRISTOPHER ANDREW
IPC: H04N19/00
Filed: 2012-07-30
Granted: 2015-10-29
Abstract: A method for decoding video includes receiving a frame of the video that includes at least one slice and at least one tile. Each of the at least one slice and the at least one tile are not all aligned with one another. Each of the at least one slice is characterized that it is decoded independently of the other the at least one slice. Each of the at least one tile is characterized that it is a rectangular region of the frame and having coding units for the decoding arranged in a raster scan order. The at least one tile of the frame are collectively arranged in a raster scan order of the frame.
Patent AU-2012321024-B2 (AU)
Title: Vacuum pump
Inventor: FELBER ARMIN
IPC: A61M1/00
Filed: 2012-09-27
Granted: 2015-09-03
Abstract: The invention relates to a vacuum pump for generating a negative pressure, comprising a pump chamber (14, 15) having an inlet (143) and an outlet (150), wherein the outlet (150) is fitted with a valve (3). According to the invention the pump chamber (14, 15) is provided with a pressure sensor (23, 23', 24). Said vacuum pump has a relatively accurate and inexpensive vacuum sensor. It is additionally advantageous that the sensor, being integrated in the pump chamber, is largely unsusceptible to interference and requires little space.
Patent AU-2012381038-B2 (AU)
Title: Interrogatory cell-based assays for identifying drug-induced toxicity markers
Inventor: NARAIN NIVEN RAJIN
IPC: G01N33/53
Filed: 2012-09-07
Granted: 2019-03-07
Abstract: Described herein is a discovery Platform Technology for analyzing a drug- induced toxicity condition, such as cardiotoxicity via model building.
Patent AU-2013200565-B2 (AU)
Title: C7-fluoro substituted tetracycline compounds
Inventor: ZHOU JINGYE
IPC: C07C275/16
Filed: 2013-02-04
Granted: 2015-07-09
Abstract: The present invention is directed to a compound represented by Structural Formula (A): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (A) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (A) and its therapeutic use.
Patent AU-2013201261-B2 (AU)
Title: Stabilized liquid anti-RSV antibody formulations
Inventor: ISSAACS BENJAMIN S
IPC: A61K9/00
Filed: 2013-03-05
Granted: 2016-06-23
Abstract: STABILIZED LIQUID ANTI-RSV ANTIBODY FORMULATIONS Abstract The present invention provides liquid formulations of SYNAGIS* or an antigen binding fragment thereof that immunospecifically bind to a respiratory syncytial virus 5 (RSV) antigen, which formulations exhibit stability, low to undetectable levels of aggregation, and very little to no loss of the biological activities of SYNAGIS* or an antigen-binding fragment thereof, even during long periods of storage. In particular, the present invention provides liquid formulations of SYNAGIS* or an antigen-binding fragment thereof which immunospecifically binds to a RSV antigen, which formulations 10 are substantially free of surfactant, inorganic salts, and/or other common excipients. Furthermore, the invention provides method of preventing, treating or ameliorating symptoms associated with RSV infection utilizing liquid formulations of the present invention.
Patent AU-2013205024-B2 (AU)
Title: Surf wake system for a watercraft
Inventor: GASPER DANIEL LEE
IPC: B63B35/00
Filed: 2013-04-13
Granted: 2016-11-10
Abstract: An adjustable surf wake system enhances a wake formed by a watercraft travelling through water. The system may include a flap for deflecting water traveling past the stern of the watercraft, and/or a positioner operably connected to the flap for positioning the flap relative to a longitudinal axis of the watercraft between a neutral position and an outward position. Positioning a port flap in its extended position enhances a starboard surf wake, and positioning the starboard flap in its extended position enhances a port surf wake. C-'*
Patent AU-2013212634-B2 (AU)
Title: Light-based touch surface with curved borders and sloping bezel
Inventor: HOLMGREN STEFAN
IPC: G06F3/042
Filed: 2013-01-21
Granted: 2014-12-18
Abstract: A light-based touch-sensitive surface, including a housing, a surface attached to the housing for receiving touch input, a plurality of light sources in the housing for emitting light that crosses the surface, a plurality of light receivers in the housing for detecting the light emitted by the light sources, a curved lens adjacent to the surface through which the light emitted by the light sources passes, including two substantially similarly curved exterior panels, one of which forms a curved rim for the surface, and a calculating unit in said housing, connected to the light receivers, for calculating a touch location based on an absence of light expected to be received by the receivers.
Patent AU-2013249429-B2 (AU)
Title: Targeted therapeutics
Inventor: CHIMMANAMADA DINESH U
IPC: C07K7/04
Filed: 2013-04-16
Granted: 2017-03-30
Abstract: The present invention provides pharmacological compounds including an effector moiety conjugated to a binding moiety that directs the effector moiety to a biological target of interest. Likewise, the present invention provides compositions, kits, and methods (e.g., therapeutic, diagnostic, and imaging) including the compounds. The compounds can be described as a protein interacting binding moiety-drug conjugate (SDC-TRAP) compounds, which include a protein interacting binding moiety and an effector moiety. For example, in certain embodiments directed to treating cancer, the SDC-TRAP can include an Hsp90 inhibitor conjugated to a cytotoxic agent as the effector moiety.
Patent AU-2013266290-B2 (AU)
Title: Percutaneous implantation of an electrical stimulation lead for stimulating dorsal root ganglion
Inventor: PIANCA ANNE MARGARET
IPC: A61B17/34
Filed: 2013-05-22
Granted: 2016-03-10
Abstract: A method of implanting an electrical stimulation lead to stimulate a dorsal root ganglion includes providing an electrical stimulation lead having a distal end, a proximal end, a longitudinal length, electrodes disposed along the distal end of the lead, terminals disposed on the proximal end of the body, a plurality of conductors electrically coupling the electrodes to the terminals. The method further includes sequentially inserting a series of hollow introducers into the back of a patient to open a passage to the dorsal root ganglion. Each introducer in the series has an inner diameter larger than an inner diameter of a preceding introducer in the series. The method also includes implanting the electrical stimulation lead through the passage formed using the series of hollow introducers. Upon implantation of the electrical stimulation lead, at least one of the plurality of electrodes is adjacent the dorsal root ganglion.
Patent AU-2013273617-B2 (AU)
Title: Brassiere with inflation/deflation assembly
Inventor: FLEETON GARTH
IPC: A41C3/14
Filed: 2013-12-13
Granted: 2015-06-25
Abstract: 10 A brassiere comprising: breast cups for supporting a breast of a wearer; each said breast cups including at least one inflatable air envelope having at least one internal space which receives air from at least one air pump; 15 connection means allowing c6mmunicating between a pump and the at least one inflatable envelope, such that when a pump is. actuated, the at least one inflatable envelope is air inflated.
Patent AU-2013284741-B2 (AU)
Title: Video predictive encoding device, video predictive encoding method, video predictive encoding program, video predictive decoding device, video predictive decoding method, and video predictive decoding program
Inventor: TAKIUE JUNYA
IPC: H04N19/50
Filed: 2013-05-24
Granted: 2016-05-05
Abstract: Conventional methods for a NAL unit header have an inefficient design in which bits are allocated to each of nal_ref_flag and nal_unit_type even if the value of nal_ref_flag is uniquely determined according to the value of nal_unit_type. The video predictive encoding device according to the present invention is equipped with an input means that inputs a plurality of images that constitute a video, and an encoding means that encodes the plurality of images using either an intra prediction method or an inter prediction method, generates compressed image data, and packetizes the compressed image data together with packet header information. The packet header information includes picture type. The encoding means determines the picture type to uniquely show whether an encoded picture data is used as a reference when decoding another picture.
Patent AU-2013302519-B2 (AU)
Title: Deuterated baricitinib
Inventor: TUNG ROGER D
IPC: A61P19/02
Filed: 2013-08-15
Granted: 2017-11-02
Abstract: The present invention in one embodiment provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula I are as defined in the specification.
Patent AU-2014200386-B2 (AU)
Title: Fluid delivery system for an oral care implement
Inventor: BOYD THOMAS
IPC: A46B15/00
Filed: 2014-01-23
Granted: 2015-09-17
Abstract: A fluid delivery system usable in an oral care implement and a reservoir containing a flowable substance. A capillary channel formed of one or more wicking or capillary members extends through at least a portion of the oral care implement to deliver flowable substance(s) through one or more outlets via capillary action. In one embodiment, the rate of fluid flow through the capillary channel is different in at least a first flow section than in a second flow section. In another embodiment, the rate of flow between flow sections of the wicking member is different than in at least one of the flow sections. A variety of flowable substances can be administered for therapeutic, hygienic, and/or other benefits, such as fresh breath, tooth whitening, tooth sensitivity, plaque and/or tartar control, or producing sensations of heat, cool, or tingling. WO 2011/106017 PCT/US2O1O/025605 ~ b :f f
Patent AU-2014200597-B2 (AU)
Title: Autonomous aircraft
Inventor: CHILDRESS JAMES J
IPC: B64B1/20
Filed: 2014-02-04
Granted: 2017-02-16
Abstract: AUTONOMOUS AIRCRAFT Systems and methods to launch an aircraft are disclosed. In one embodiment, a system (100) comprises an electrically powered buoyant aircraft (110), a control system (130) to maneuver the aircraft and a tether (140) adapted to couple to the aircraft (110) and to a ground-based power supply (180) to provide power to the aircraft (110) while the aircraft (110) is coupled to the tether (140), wherein the aircraft (110) can disconnect autonomously from the tether (140) in response to a command signal. Other embodiments may be described. -2 140 Power Supply Fic. lB iSQ FIG. ID FIG. IC
Patent AU-2014201305-B2 (AU)
Title: Sterilisation of polymerisable monomer
Inventor: VOGT SEBASTIAN
IPC: A61L24/04
Filed: 2014-03-07
Granted: 2015-03-19
Abstract: Sterilisation of polymerisable monomer Abstract The invention relates, inter alia, to a method for sterilisation of a polymerisable monomer. Said method provides a mixture (1) that contains at least the polymerisable monomer, a compound (a) and a compound (b), whereby compound (a) is selected from compounds (al) represented through general formula (1), whereby R1, R2, R3, and R4, independently of each other, represent a substituted or non substituted alkyl residue, halogen residue, nitro residue or cyano residue, compounds (a2) that are selected from the group consisting of dimers of compounds (al), and compounds (a3) that are selected from the group consisting of dialkyldicarbonates, and compound (b) is selected from the group consisting of water and alcohols.
Patent AU-2014201975-B2 (AU)
Title: Heavy wall quenched and tempered seamless steel pipes and related method for manufacturing said steel pipes
Inventor: ANELLI ETTORE
IPC: C22C38/28
Filed: 2014-04-07
Granted: 2017-09-28
Abstract: Abst ract seamless ~ ~ ~ Son qeceantmprd Stel wip having a wail thicknessVI (WTr tha o equal to 3 m and lower than or equ to 80 mm, wherein the steel pipe has a chemical composition consisting of I&50-0085 wtC 0.80.6 wt% Mn, 010-045 wt% Si 010-00 wt% (I (08-04 wt% Ni,008-040 wt% Mo, 0.0.5-0.040 wt% AlO.008-00050 wt% Ca, 000 0A 0vt% N. 0.00A04 wt% Nb, 000-0.02 wt Ti 0001030 wt% Zr, 0000.030 t% Ta based on the composition weight, the remaining being iron and impurities; said impurities comprising 0,000>00 wt% V; wherein, defining a first parameter P1i = 50 x C + Cr + 10 x Moa ± 0 a V. the chemical composition satisfies a first condition P1 1 8.; wherein the quenched and tempered steel pipe has at md thinss, a iosetruature comprising, in volume percentage, tempered bainite geater than or equal to 50% and ferriteMy5 tower than or equal to 50%; wherein the quenched and tempered steel pipe has at a distance up to 2 mm starting from outer and inner surfaces of the steel pipe, a nmirostrueture consisting of in volurre perentage, tempered martensitelower than 70% and tempered haine higher than A0% and wheMin the maximum hardness values, measured at 1.5-20 mm depth from the outer and inner surfaces are below 2351W10 "'A N' ""'3 ''$ 3 3~4 \zZ< ~~t' 1<' I~. >1~ rc;~ -3 ~ 3 4 4 ~'4 N. 'Nt N' s 7 ( '~"'t "A k I ~ \'~ 'N 3$ '44 ("3 "'> r~ t"N ~"> 'N'N ""N c' \ N'~' S"'\ x'~' \~s -' \"" N' '~'N r~'~ Y'~ ~'N'\ "NS 'zN't' kNfl N" ""N kNx0 ~ ' NT SN'> \ 4Ct "N -